Stay updated with breaking news from Components agency. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
You get a good stretch, the home stretch of the program today. Again, there will be three panels coming up, followed by two towards them, as i talked about before, very special guest will receive a lifetime award today, so, you certainly will want to be here for that. The next panel is with the chief security Information Officer is the cyber leader panel, they are fortunate to have some great people appear to talk to us today, the moderator today is the Vice President of Public Sector. Joining him is the chief Information Security officer from the u. S. Department of justice. The chief Information Security information ist from homeland security, and a deputy cio for cybersecurity and the dod chi ....
The director of the National Security agency, general paul nakasone, joined other National Security professionals to talk about the foreign Intelligence Surveillance act, and cybersecurity, in a discussion at the center for strategic and International Studies in washington, d. C. This is about one hour and 15 minutes. General, it is a real honor to be on the stage with you. For me, it is a personal treat. You became the director of the nsa and the commander of cybercom a little over five years ago. And before that, when i first had the pleasure of missing you when you are the head of cyber, you are the head of army cyber, he went from being a one star to a four star in just six years, an impressive sign of how wellregarded you are. I would li ....
[ is distinct conversations ]. And live here this morning on c spann span 3, a discussion about transparency and oversight at the food and Drug Administration. Well be hearing from dr. Scott gottlieb starting off the conference. Introductions under way. Efforts to pass and implement the food safety modernization act, focus on medical devices, especially the potential of using the unique device identifier to improve monitoring devices throughout the product lifecycle. We have successfully worked on products 10 to courage innovation particularly around antibiotics and 10 to sure appropriate use of them. We focused on drug safety and transparency in the supply chain and especially on the safety of compounded drugs. Among other things, pew submitted transparency to the task force back in 2010 if the. They touch on some of the topics well be discussing today. Reading the background papers for todays meet regular mind med of a meet ....